|
1
|
Abdi J, Rastgoo N, Li L, Chen W and Chang
H: Role of tumor suppressor p53 and micro-RNA interplay in multiple
myeloma pathogenesis. J Hematol Oncol. 10:1692017. View Article : Google Scholar
|
|
2
|
Ahmad N, Haider S, Jagannathan S, Anaissie
E and Driscoll JJ: MicroRNA theragnostics for the clinical
management of multiple myeloma. Leukemia. 28:732–738. 2014.
View Article : Google Scholar
|
|
3
|
Troppan K, Wenzl K, Pichler M, Pursche B,
Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C,
Neumeister P and Deutsch A: miR-199a and miR-497 are associated
with better overall survival due to increased chemosensitivity in
diffuse large β-cell lymphoma patients. Int J Mol Sci.
16:18077–18095. 2015. View Article : Google Scholar :
|
|
4
|
Rastgoo N, Abdi J, Hou J and Chang H: Role
of epigenetics-microRNA axis in drug resistance of multiple
myeloma. J Hematol Oncol. 10:1212017. View Article : Google Scholar
|
|
5
|
Sevcikova S, Kubiczkova L, Sedlarikova L,
Slaby O and Hajek R: Serum miR-29a as a marker of multiple myeloma.
Leuk Lymphoma. 54:189–191. 2013. View Article : Google Scholar
|
|
6
|
Fang T, Wu Q, Zhou L, Mu S and Fu Q:
miR-106b-5p and miR-17-5p suppress osteogenic differentiation by
targeting Smad5 and inhibit bone formation. Exp Cell Res.
347:74–82. 2016. View Article : Google Scholar
|
|
7
|
Xu D, Gao Y, Hu N, Wu L and Chen Q:
miR-365 Ameliorates dexamethasone-induced suppression of
osteogenesis in MC3T3-E1 cells by targeting HDAC4. Int J Mol Sci.
18:2017. View Article : Google Scholar
|
|
8
|
Tang CM, Zhang M, Huang L, Hu ZQ, Zhu JN,
Xiao Z, Zhang Z, Lin QX, Zheng XL, Yang M, et al: CircRNA_000203
enhances the expression of fibrosis-associated genes by
derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac
fibroblasts. Sci Rep. 7:403422017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhai Y, Tyagi SC and Tyagi N: Cross-talk
of MicroRNA and hydrogen sulfide: A novel therapeutic approach for
bone diseases. Biomed Pharmacother. 92:1073–1084. 2017. View Article : Google Scholar
|
|
10
|
Kang H, Chen H, Huang P, Qi J, Qian N,
Deng L and Guo L: Glucocorticoids impair bone formation of bone
marrow stromal stem cells by reciprocally regulating
microRNA-34a-5p. Osteoporos Int. 27:1493–1505. 2016. View Article : Google Scholar
|
|
11
|
Lu Y, Li F, Xu T and Sun J: miRNA-497
Negatively regulates the growth and motility of chondrosarcoma
cells by targeting Cdc25A. Oncol Res. 23:155–163. 2016. View Article : Google Scholar
|
|
12
|
Kong XJ, Duan LJ, Qian XQ, Xu D, Liu HL,
Zhu YJ and Qi J: Tumor-suppressive microRNA-497 targets IKKbeta to
regulate NF-kappaB signaling pathway in human prostate cancer
cells. Am J Cancer Res. 5:1795–804. 2015.
|
|
13
|
Lin Z, Zhao J, Wang X, Zhu X and Gong L:
Overexpression of microRNA-497 suppresses cell proliferation and
induces apoptosis through targeting paired box 2 in human ovarian
cancer. Oncol Rep. 36:2101–2107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ge L, Zheng B, Li M, Niu L and Li Z:
MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in
vivo. Oncol Lett. 11:2207–2212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei C, Luo Q, Sun X, Li D, Song H, Li X,
Song J, Hua K and Fang L: MicroRNA-497 induces cell apoptosis by
negatively regulating Bcl-2 protein expression at the
posttranscriptional level in human breast cancer. Int J Clin Exp
Pathol. 8:7729–7739. 2015.
|
|
16
|
Shao XJ, Miao MH, Xue J, Xue J, Ji XQ and
Zhu H: The down-regulation of MicroRNA-497 contributes to cell
growth and cisplatin resistance through PI3K/Akt pathway in
osteo-sarcoma. Cell Physiol Biochem. 36:2051–2062. 2015. View Article : Google Scholar
|
|
17
|
Li W, Jin X, Deng X, Zhang G, Zhang B and
Ma L: The putative tumor suppressor microRNA-497 modulates gastric
cancer cell proliferation and invasion by repressing eIF4E. Biochem
Biophys Res Commun. 449:235–240. 2014. View Article : Google Scholar
|
|
18
|
Yu T, Zhang X, Zhang L, Wang Y, Pan H, Xu
Z and Pang X: MicroRNA-497 suppresses cell proliferation and
induces apoptosis through targeting PBX3 in human multiple myeloma.
Am J Cancer Res. 6:2880–2889. 2016.
|
|
19
|
Lionetti M, Musto P, Di Martino MT, Fabris
S, Agnelli L, Todoerti K, Tuana G, Mosca L, Gallo Cantafio ME,
Grieco V, et al: Biological and clinical relevance of miRNA
expression signatures in primary plasma cell leukemia. Clin Cancer
Res. 19:3130–3142. 2013. View Article : Google Scholar
|
|
20
|
Wu R, Tang S, Wang M, Xu X, Yao C and Wang
S: MicroRNA-497 induces apoptosis and suppresses proliferation via
the Bcl-2/Bax-Caspase9-Caspase3 pathway and cyclin D2 protein in
HUVECs. PLoS One. 11:e01670522016. View Article : Google Scholar :
|
|
21
|
Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang
B, Shu Y and Liu P: miR-497 modulates multidrug resistance of human
cancer cell lines by targeting BCL2. Med Oncol. 29:384–391. 2012.
View Article : Google Scholar
|
|
22
|
Shen L, Li J, Xu L, Ma J, Li H, Xiao X,
Zhao J and Fang L: miR-497 induces apoptosis of breast cancer cells
by targeting Bcl-w. Exp Ther Med. 3:475–480. 2012. View Article : Google Scholar
|
|
23
|
Yadav S, Pandey A, Shukla A, Talwelkar SS,
Kumar A, Pant AB and Parmar D: miR-497 and miR-302b regulate
ethanol-induced neuronal cell death through BCL2 protein and cyclin
D2. J Biol Chem. 286:37347–37357. 2011. View Article : Google Scholar
|
|
24
|
Zhu D, Tu M, Zeng B, Cai L, Zheng W, Su Z
and Yu Z: Up-regulation of miR-497 confers resistance to
temozolomide in human glioma cells by targeting mTOR/Bcl-2. Cancer
Med. 6:452–462. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gandolfi S, Laubach JP, Hideshima T,
Chauhan D, Anderson KC and Richardson PG: The proteasome and
proteasome inhibitors in multiple myeloma. Cancer Metastasis Rev.
36:561–584. 2017. View Article : Google Scholar
|
|
26
|
Huang J, Zhou Y, Thomas GS, Gu Z, Yang Y,
Xu H, Tricot G and Zhan F: NEDD8 inhibition overcomes CKS1B-Induced
drug resistance by upregulation of p21 in multiple myeloma. Clin
Cancer Res. 21:5532–5542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Campanella A, Santambrogio P, Fontana F,
Frenquelli M, Cenci S, Marcatti M, Sitia R, Tonon G and Camaschella
C: Iron increases the susceptibility of multiple myeloma cells to
bortezomib. Haematologica. 98:971–979. 2013. View Article : Google Scholar :
|
|
28
|
Florine EM, Miller RE, Porter RM, Evans
CH, Kurz B and Grodzinsky AJ: Effects of dexamethasone on
mesenchymal stromal cell chondrogenesis and aggrecanase activity:
Comparison of agarose and Self-Assembling peptide scaffolds.
Cartilage. 4:63–74. 2013. View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
30
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:1792005. View Article : Google Scholar
|
|
31
|
Wang YG, Han XG, Yang Y, Qiao H, Dai KR,
Fan QM and Tang TT: Functional differences between AMPK alpha1 and
alpha2 subunits in osteogenesis, osteoblast-associated induction of
osteoclastogenesis, and adipogenesis. Sci Rep. 6:327712016.
View Article : Google Scholar
|
|
32
|
Song L, Zhao J, Zhang X, Li H and Zhou Y:
Icariin induces osteoblast proliferation, differentiation and
mineralization through estrogen receptor-mediated ERK and JNK
signal activation. Eur J Pharmacol. 714:15–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu
G, Mao H and Qiu Y: MicroRNA-26b inhibits cell proliferation and
cytokine secretion in human RASF cells via the
Wnt/GSK-3beta/beta-catenin pathway. Diagn Pathol. 10:722015.
View Article : Google Scholar
|
|
34
|
Wang L, Jiang CF, Li DM, Ge X, Shi ZM, Li
CY, Liu X, Yin Y, Zhen L, Liu LZ and Jiang BH: MicroRNA-497
inhibits tumor growth and increases chemosensitivity to
5-fluorouracil treatment by targeting KSR1. Oncotarget.
7:2660–2671. 2016.
|
